期刊
NATURE IMMUNOLOGY
卷 18, 期 12, 页码 1299-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3853
关键词
-
类别
资金
- US National Institutes of Health [U19-AI109965, R01-AI103083, R01-AI131685, R01-AI1033, R21-AI11757511]
- University of North Carolina Cancer Research Fund
- Grants-in-Aid for Scientific Research [17H05070] Funding Source: KAKEN
NLRX1 is unique among the nucleotide-binding-domain and leucine-rich-repeat (NLR) proteins in its mitochondrial localization and ability to negatively regulate antiviral innate immunity dependent on the adaptors MAVS and STING. However, some studies have suggested a positive regulatory role for NLRX1 in inducing antiviral responses. We found that NLRX1 exerted opposing regulatory effects on viral activation of the transcription factors IRF1 and IRF3, which might potentially explain such contradictory results. Whereas NLRX1 suppressed MAVS-mediated activation of IRF3, it conversely facilitated virus-induced increases in IRF1 expression and thereby enhanced control of viral infection. NLRX1 had a minimal effect on the transcription of IRF1 mediated by the transcription factor NF-kappa B and regulated the abundance of IRF1 post-transcriptionally by preventing translational shutdown mediated by the double-stranded RNA (dsRNA)-activated kinase PKR and thereby allowed virus-induced increases in the abundance of IRF1 protein.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据